Cardiff and Vale University Health Board partners with Nervecentre for digital transformation
Cardiff and Vale University Health Board has chosen Nervecentre to supply its electronic prescribing and medicines administration solution, as part of its commitment to embracing digital technology for clinical service enhancement. The cloud-based EPMA software will be implemented in all nine hospitals within the health board, ushering in a digital-first approach to medicines management.
This move is set to revolutionize the way 7,000 clinicians prescribe medications, providing them with improved visibility of prescribing and administration processes, ultimately leading to quicker response times and freeing up more time for patient care.
David Thomas, the director of digital and health intelligence at Cardiff and Vale, emphasized the importance of digital transformation in shaping the future of healthcare services. He expressed excitement about collaborating with Nervecentre to introduce the new EPMA system, which is expected to bring about positive culture change, enhance patient safety, and increase efficiency.
The chosen modern cloud platform not only fosters collaboration with neighboring health boards, but also allows for rapid development and implementation of functional changes, supporting agile service transformation with zero planned downtime for updates. Real-time data accessible on mobile devices will further enhance hospital safety and efficiency.
Nervecentre’s achievement in securing a place on the all-Wales EPMA framework, with Cardiff and Vale being the first health board to adopt its EPMA system, speaks volumes about the company’s expertise in delivering innovative solutions for healthcare providers. Nervecentre CEO, Paul Volkaerts, expressed his enthusiasm for the partnership and highlighted the benefits of cloud technology in enabling successful clinical service transformation.
